Anti-angiogenic drugs can block multiple immunosuppressive effects of VEGF and induce various vascular-regulating effects, such as vascular normalization leading to increased blood flow and perfusion within the tumor and inhibition of endothelial cell apoptosis effects on T cells. The gene discussed is VEGFA; the disease is neoplasm.